Minimally Invasive Treatment Of Adrenal Pathology
Publication Date: February 1, 2013
Last Updated: March 14, 2022
Recommendations
Minimally invasive adrenalectomy is associated with less postoperative pain, shorter hospital stay, earlier recovery, and similar long-term outcomes compared with open surgery and has been established as the preferred approach to all non-primary adrenal cancer pathology. (Moderate, Strong)
317067
Several approaches to laparoscopic adrenalectomy have been described in the literature. Surgeons should choose the approach they are most familiar with, have had training in, and have the best patient outcomes with. (Moderate, Strong)
317067
Surgeons should also take into consideration that in specific clinical circumstances some surgical approaches to adrenalectomy may be more beneficial than others: (, )
317067
In patients with previous abdominal surgery, a retroperitoneal approach may be associated with less operative time and fewer complications. (Low, Weak)
317067
For bilateral adrenalectomies, the posterior retroperitoneal approach may be advantageous, as it eliminates patient repositioning during the case. (Low, Weak)
317067
In morbidly obese patients (BMI >35 kg/m2) and for large tumors (>6 cm), the lateral transabdominal approach may increase the feasibility of the procedure compared with the other approaches. (Low, Weak)
317067
Compared with standard laparoscopic techniques, robotic adrenalectomy may offer advantages for large tumors and in morbidly obese patients. (Very Low, Weak)
However, given the increased cost, longer operative times, and lack of clear patient outcome benefits using this technique, additional higher quality evidence is needed before a firm recommendation can be provided.
317067
Based on the available evidence, single port adrenalectomy is feasible and safe when undertaken by an experienced surgeon but offers little if any advantage over other standard laparoscopic approaches to adrenalectomy. Additional, better quality evidence is needed before this approach can be recommended. (Very Low, Weak)
317067
Partial adrenalectomy is safe and feasible in the hands of appropriately trained surgeons. For patients requiring bilateral adrenalectomy, such as for hereditary pheochromocytomas, laparoscopic cortical sparing surgery may be the procedure of choice. (Low, Weak)
Additional evidence is needed before a recommendation can be provided for partial adrenalectomy of single gland, non-hereditary tumors.
317067
The classic teaching for early vein control during open adrenalectomy has not been confirmed for laparoscopic adrenalectomy, because patient outcomes do not appear to be affected by early versus late ligation. Thus, the type and timing of adrenal vein control depends on surgeon preference and the specific anatomic variables associated with each case. (Low, Weak)
317067
For adrenocortical carcinoma, the best determinant of patient outcomes is an appropriate oncologic resection that includes en bloc resection of any contiguous involved structures and regional lymphadenectomy. Thus, an open approach to resection may be best. If a laparoscopic approach is chosen (due to unknown malignancy status preoperatively or suspected early stage carcinoma), conversion to open surgery is strongly recommended when difficult dissection is encountered due to tumor adhesion or invasion or enlarged lymph nodes are seen. (Low, Strong)
317067
Solitary metastases to the adrenal gland without evidence of local invasion can be approached laparoscopically by a surgeon skilled in advanced laparoscopy and adrenal surgery. (Very Low, Weak)
317067
If local invasion is found intraoperatively, conversion to an open approach is warranted. (Very Low, Strong)
317067
Large adrenal tumors without pre- or intraoperative evidence of primary adrenal cortical carcinoma can be approached laparoscopically by a surgeon skilled in advanced laparoscopy and adrenal surgery. (Very Low, Weak)
317067
Laparoscopic adrenalectomy for larger tumors may be associated with increased operating room times, blood loss, and conversion rate to open surgery. (Very Low, Weak)
317067
If there is any evidence for carcinoma found intraoperatively, conversion to an open approach is warranted (should be strongly considered). (Very Low, Strong)
317067
Before laparoscopic adrenalectomy for pheochromocytoma, alpha adrenergic receptor blockade should be considered in all patients. When used preoperatively, alpha blockade should be continued until signs of orthostatic hypotension are evident. (Moderate, Weak)
317067
Short acting alpha blockers may be preferable to long acting ones. Beta blockade should also be considered in appropriately selected patients and should only be instituted following adequate alpha blockade. (Low, Weak)
317067
Invasive hemodynamic monitoring should be considered during LA for pheochromocytomas. (Low, Strong)
317067
To minimize hemodynamic instability due to catecholamine release during surgery, minimization of direct manipulation or compression of the adrenal gland is necessary. (Low, Strong)
317067
Early ligation of the vein does not prevent hemodynamic instability. (Very Low, Weak)
317067
Due to the potential for hemodynamic instability after pheochromocytoma resection, all patients should be closely monitored in the early postoperative phase. (Low, Strong)
317067
Capsular disruptions of the adrenal gland during surgery should be avoided to minimize the risk of disease recurrence. (Very Low, Weak)
317067
Given the lack of clear predictors of malignancy to detect recurrences, patients with pheochromocytoma should be monitored long term with blood pressure measurements and serum and/or urinary metanephrine levels. (Low, Strong)
317067
Learning curve
Minimally invasive adrenalectomy is associated with a learning curve that may be difficult to overcome given the paucity of these cases in general practice. Dedicated, advanced training should be pursued by surgeons unfamiliar with this technique. Until proficiency with laparoscopic adrenalectomy is attained, consideration should be given to referral to a center with expertise in minimally-invasive adrenal surgery. (Low, Strong)
317067
Title
Minimally Invasive Treatment Of Adrenal Pathology
Authoring Organization
Society of American Gastrointestinal and Endoscopic Surgeons
Publication Month/Year
February 1, 2013
Last Updated Month/Year
June 22, 2023
External Publication Status
Published
Country of Publication
US
Document Objectives
The guidelines for the minimally invasive surgical treatment of adrenal pathology are a series of systematically developed statements to educate and guide the surgeon (and patient) in the appropriate use of minimally invasive techniques for the treatment of adrenal disease.
Target Patient Population
Patients with adrenal disease
Inclusion Criteria
Female, Male, Adolescent, Adult, Child, Older adult
Health Care Settings
Ambulatory, Hospital, Operating and recovery room, Outpatient
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Assessment and screening, Management, Treatment
Diseases/Conditions (MeSH)
D013502 - General Surgery, D000315 - Adrenalectomy, D000314 - Adrenal Rest Tumor, D010673 - Pheochromocytoma
Keywords
surgery, adrenal pathology, adrenal disease, adrenalectomy